Alcon (ALC) is well-poised to grow in the coming quarters, driven by its new product offerings. The performance of the Vision Care arm also appears encouraging. Strong financial stability in times of economic turmoil bodes well for the stock. However, concerns remain about the macroeconomic headwinds, which may strain the company’s margin performance. Competitive disadvantages also add to the worry. In the past year, this Zacks Rank #2 (Buy) stock has advanced 14.6% compared with the 12.1% rise of the indus ...